27 Sep 2023 --- Chr. Hansen revealed it has achieved a significant achievement for its human milk oligosaccharide (HMO) offerings. The Chinese Ministry of Agriculture and Rural Affairs (MARA) has granted approval in the first step of its process for three key HMOs – 2′-fucosyllactose (2’-FL), lacto-n-tetraose (LNT) and 3-fucosyllactose (3-FL).
